Biocryst Pharmaceuticals Inc (BCRX)
R&D to Revenue
23.81%
Quarterly · Period ending:
BCRX R&D to Revenue
Latest reported23.81%period ending
Latest reported23.81%period ending
BCRX Quarterly R&D/Revenue (0.00% → 23.81%)
Latest values, visible window
High-resolution chart · PNG
BCRX r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 74.6835% | |
| 359.8862% | |
| -212.3535% | |
| 3,396.6667% | |
| 560.5809% | |
| 37.0725% | |
| 0% | |
| 1,900% | |
| 81.8182% | |
| 1,100% | |
| 400% | |
| 40% | |
| 2,600% | |
| 2,700% | |
| 0% | |
| 2,400% | |
| 178.5714% | |
| 580% | |
| 0% | |
| 733.3333% | |
| 111.7647% | |
| 1,500% | |
| 0% | |
| 1,700% | |
| 1,300% | |
| 1,250% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |